Abstract
Background:
Detectable troponin below the 99th percentile may reflect an underlying cardiac abnormality which might entail prognostic consequences. This study aimed to investigate the prognosis of patients admitted to an emergency department (ED) with detectable troponin below the 99th percentile reference limit who did not present with an acute coronary syndrome (ACS).
Methods:
We analysed the clinical data of all consecutive patients admitted to the ED during the years 2012 and 2013 in whom cardiac troponin was requested by the attending clinician (cTnI Ultra Siemens, Advia Centaur). Patients with troponin below the 99th percentile of the reference population (40 ng/L) and who did not have a diagnosis of ACS were selected, and their mortality was evaluated in a 2-year follow-up.
Results:
A total of 2501 patients had a troponin level below the reference limit, with 43.9% of those showing detectable levels (>6 ng/L and <40 ng/L). Patients with detectable levels were elderly and had a higher prevalence of cardiovascular history and more comorbidities. The total mortality in the 2-year follow-up was 12.4% in patients with detectable troponin and 4.5% in patients with undetectable troponin (p<0.001). In the Cox multivariate regression analysis, the detectable troponin was an independent marker of mortality at 2 years (HR 1.62, 95% CI 1.07–2.45, p=0.021).
Conclusions:
Detectable troponin I below the 99th percentile is associated with higher mortality risk at 2-year follow-up in patients admitted to the ED who did not present with ACS.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33:2252–7.10.1093/eurheartj/ehs154Search in Google Scholar PubMed
2. Brush JE, Kaul S, Krumholz HM. Troponin testing for clinicians. J Am Coll Cardiol 2016;68:2365–75.10.1016/j.jacc.2016.08.066Search in Google Scholar PubMed
3. Cediel G, Gonzalez-del-Hoyo M, Carrasquer A, Sanchez R, Boqué C, Bardají A. Outcomes with type 2 myocardial infarction compared with non-ischemic myocardial injury. Heart 2017;103:616–22.10.1136/heartjnl-2016-310243Search in Google Scholar PubMed
4. Bardají A, Cediel GN, Carrasquer A, De Castro RN, Sánchez R, Boqué C. Troponina elevada en pacientes sin síndrome coronario agudo [Troponin elevation in patients without acute coronary syndrome]. Rev Esp Cardiol 2015;68:469–76.10.1016/j.recesp.2014.10.018Search in Google Scholar
5. Pham MX, Whooley MA, Evans GT, Liu C, Emadi H, Tong W, et al. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Am Heart J 2004;148:776–82.10.1016/j.ahj.2004.03.058Search in Google Scholar PubMed
6. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J. Cardiac troponin assays: Guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 2017;63:73–81.10.1373/clinchem.2016.255109Search in Google Scholar PubMed
7. Jaffe AS, Ordonez-Llanos J. High-sensitivity cardiac troponin: from theory to clinical practice. Rev Esp Cardiol 2013;66: 687–91.10.1016/j.rec.2013.04.020Search in Google Scholar PubMed
8. Irfan A, Twerenbold R, Reiter M, Reichlin T, Stelzig C, Freese M, et al. Determinants of high-sensitivity troponin t among patients with a non-cardiac cause of chest pain. Am J Med 2012;125:491–8.10.1016/j.amjmed.2011.10.031Search in Google Scholar PubMed
9. Carlson ER, Percy RF, Angiolillo DJ, Conetta DA. Prognostic significance of troponin T elevation in patients without chest pain. Am J Cardiol 2008;102:668–71.10.1016/j.amjcard.2008.04.046Search in Google Scholar PubMed
10. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581–98.10.1016/j.jacc.2012.08.001Search in Google Scholar PubMed
11. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958–65.10.1161/CIRCULATIONAHA.105.609974Search in Google Scholar PubMed
12. Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E, Diego S, et al. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults. Results from the Rancho Bernardo Study. J Am Coll Cardiol 2008;52:450–9.10.1016/j.jacc.2008.04.033Search in Google Scholar PubMed PubMed Central
13. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. J Am Med Assoc 2010;304:2503–12.10.1001/jama.2010.1768Search in Google Scholar PubMed PubMed Central
14. Daniels LB, Clopton P, DeFilippi CR, Sanchez OA, Bahrami H, Lima JA, et al. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2015;170:1170–83.10.1016/j.ahj.2015.09.010Search in Google Scholar PubMed PubMed Central
15. Thorsteinsdottir I, Aspelund T, Gudmundsson E, Eiriksdottir G, Harris TB, Launer LJ, et al. High-sensitivity cardiac troponin I is a strong predictor of cardiovascular events and mortality in the ages-Reykjavik community-based cohort of older individuals. Clin Chem 2016;62:623–30.10.1373/clinchem.2015.250811Search in Google Scholar PubMed PubMed Central
16. Iribarren C, Chandra M, Rana JS, Hlatky MA, Fortmann SP, Quertermous T, et al. High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart 2016;102:1177–82.10.1136/heartjnl-2015-309136Search in Google Scholar PubMed
17. Álvarez I, Hernández L, García H, Villamandos V, López MG, Palazuelos Molinero J, et al. Troponina T ultrasensible en pacientes asintomáticos de muy alto riesgo cardiovascular. Registro TUSARC. Rev Esp Cardiol 2017;70:261–6.10.1016/j.recesp.2016.08.018Search in Google Scholar
18. Love SA, Sandoval Y, Smith SW, Nicholson J, Cao J, Ler R, et al. Incidence of undetectable, measurable, and increased cardiac troponin I concentrations above the 99th percentile using a high-sensitivity vs. a contemporary assay in patients presenting to the emergency department. Clin Chem 2016;62:1115–9.10.1373/clinchem.2016.256305Search in Google Scholar PubMed
19. Reichlin T, Twerenbold R, Reiter M, Steuer S, Bassetti S, Balmelli C, et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med 2012;125:1205–13.10.1016/j.amjmed.2012.07.015Search in Google Scholar PubMed
20. Arenja N, Reichlin T, Drexler B, Oshima S, Denhaerynck K, Haaf P, et al. Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. J Intern Med 2012;271:598–607.10.1111/j.1365-2796.2011.02469.xSearch in Google Scholar PubMed
21. van Wijk S, Jacobs L, Eurlings LW, van Kimmenade R, Lemmers R, Broos P, et al. Troponin T measurements by high-sensitivity vs. conventional assays for risk stratification in acute dyspnea. Clin Chem 2012;58:284–92.10.1373/clinchem.2011.175976Search in Google Scholar PubMed
22. Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts outcome in syncope. Emerg Med J 2012;29:1001–3.10.1136/emermed-2012-201332Search in Google Scholar PubMed
23. Vafaie M, Slagman A, Möckel M, Hamm C, Huber K, Müller C, et al. Prognostic value of undetectable hs troponin T in suspected acute coronary syndrome. Am J Med 2016;129:274–82.10.1016/j.amjmed.2015.10.016Search in Google Scholar PubMed
24. Bandstein N, Ljung R, Johansson M, Holzmann MJ. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014;63:2569–78.10.1016/j.jacc.2014.03.017Search in Google Scholar PubMed
25. Patterson CC, Blankenberg S, Ben-Shlomo Y, Heslop L, Bayer A, Lowe G, et al. Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS). Int J Cardiol 2015;201:113–8.10.1016/j.ijcard.2015.07.106Search in Google Scholar PubMed PubMed Central
26. Welsh P, Hart C, Papacosta O, Preiss D, McConnachie A, Murray H, et al. Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies: does utility depend on risk thresholds for treatment? Hypertension 2016;67:309–15.10.1161/HYPERTENSIONAHA.115.06501Search in Google Scholar PubMed PubMed Central
©2018 Walter de Gruyter GmbH, Berlin/Boston
